相关实验视频
Updated: May 22, 2025

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
Published on: July 16, 2014
胰岛皮质中的溶酸受体5作为神经病痛疼痛中潜在的止痛标
Bing Wang1, Xiaozhou Feng1, Kristen Woodhouse2
1Department of Anesthesiology, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, NJ 07103, USA.
岛内皮质中的溶酸受体5 (LPA5) 对于神经损伤后的神经病痛的发展至关重要. 准LPA5为疼痛管理提供了一个有前途的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 疼痛研究 疼痛研究
- 分子生物学分子生物学
背景情况:
- 神经病痛带来了重大的临床挑战,治疗选择有限,往往导致阿片类药物依赖.
- 酸酸受体5 (LPA5) 抑制在动物神经损伤模型中表现出止痛作用,但其在与疼痛相关的大脑区域的具体作用尚不清楚.
研究的目的:
- 为了确定LPA5参与神经病痛的特定大脑区域.
- 为了研究针对神经病痛的岛屿皮层中的LPA5的治疗潜力.
主要方法:
- 在坐骨神经受伤后,在小鼠大脑区域评估Lpa5mRNA和LPA5蛋白水平.
- 利用腺相关病毒5 (AAV5) 载体,在特定的大脑区域中对Lpa5进行基因淘汰 (shRNA) 和过度表达 (全长mRNA).
- 系统地使用选择性LPA5抗剂 (RLPA-76).
- 评估了疼痛行为 (nociceptive过敏症,整体运动,过敏症) 和运动运动活动.
主要成果:
- 在神经受伤后,LPA5表达在逆侧岛屿皮层和海马体增加.
- 在岛内皮层中LPA5的淘汰,但不是海马,减弱了神经病痛的发展.
- 在岛内皮层中LPA5的过度表达加剧了原始小鼠的疼痛反应.
- 系统性LPA5对抗性缓解了既定的神经病痛行为,而不影响运动.
结论:
- 岛内皮层中的LPA5在神经病痛的发展和维持中起着至关重要的作用.
- LPA5代表了治疗神经病痛的潜在治疗标.
更多相关视频
09:39Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
Published on: February 13, 2018
08:16Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies
Published on: October 6, 2022
相关概念视频
Analgesia and Pain Management
Opioid Receptors: Overview
Nociception
Pain
Local Anesthetics: Mechanism of Action
Local anesthetics are amphiphilic molecules consisting of a hydrophobic aromatic part linked to a hydrophilic group by an ester or amide linkage. They are weak bases and are usually available as salts, which increases their solubility and stability. Once administered, LAs exist in the body either...
IP3/DAG Signaling Pathway